FDA safety actions for antidiabetic drugs marketed in the US, 1980

登录注册会员服务联系我们

FDA safety actions for antidiabetic drugs marketed in the US, 1980–2015

Published:2017-05-31 Issue:4 Volume:28 Page:197-211
ISSN:0924-6479
Container-title:International Journal of Risk & Safety in Medicine
language:
Short-container-title:JRS

Author:

Kwon Christina S.¹,Seoane-Vazquez Enrique¹²,Rodriguez-Monguio Rosa³

Affiliation:

1. International Center for Pharmaceutical Economics and Policy, MCPHS University, Boston, MA, USA

2. Brigham and Women’s Hospital, Division of General Medicine and Primary Care, Boston, MA, USA

3. School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA

Publisher

IOS Press

Subject

Public Health, Environmental and Occupational Health,Health Policy,General Medicine

Reference25 articles.

1. The past 200 years in diabetes;Polonsky;N Engl J Med,2012

2. Centers for Disease Control and Prevention. Diabetes report card 2014. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services, 2015a.

3. IMS Institute for Healthcare Informatics. Medicines use and spending in the U.S.; A review of 2015 and outlook to 2020. Parsippany, NJ: IMS Institute for Healthcare Informatics, 2016.

4. Systematic reviews to ascertain the safety of diabetes medications;Gionfriddo;Curr Diab Rep,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle – a focus on benefits and risks;Expert Opinion on Drug Safety;2021-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP